Ignite Creation Date:
2025-12-24 @ 3:56 PM
Ignite Modification Date:
2026-02-26 @ 4:14 PM
Study NCT ID:
NCT02621892
Status:
COMPLETED
Last Update Posted:
2020-04-21
First Post:
2015-12-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C
Sponsor:
Ardelyx
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Constipation Predominant Irritable Bowel Syndrome | View |
Keywords: